

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | retinal rod cell development (GO:0046548) | 9.92581967 |
| 2 | * detection of light stimulus (GO:0009583) | 9.87445768 |
| 3 | GMP metabolic process (GO:0046037) | 9.72649685 |
| 4 | * detection of light stimulus involved in visual perception (GO:0050908) | 9.54750345 |
| 5 | * detection of light stimulus involved in sensory perception (GO:0050962) | 9.54750345 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 9.21929201 |
| 7 | positive regulation of guanylate cyclase activity (GO:0031284) | 9.09409185 |
| 8 | visual perception (GO:0007601) | 8.86537127 |
| 9 | sensory perception of light stimulus (GO:0050953) | 8.76928094 |
| 10 | actin-mediated cell contraction (GO:0070252) | 8.49536378 |
| 11 | skeletal muscle contraction (GO:0003009) | 8.31694380 |
| 12 | regulation of guanylate cyclase activity (GO:0031282) | 8.18255519 |
| 13 | regulation of skeletal muscle contraction (GO:0014819) | 7.83307009 |
| 14 | * cellular response to light stimulus (GO:0071482) | 7.34788412 |
| 15 | * detection of external stimulus (GO:0009581) | 6.89285106 |
| 16 | * detection of abiotic stimulus (GO:0009582) | 6.77130042 |
| 17 | eye photoreceptor cell differentiation (GO:0001754) | 6.62434026 |
| 18 | photoreceptor cell differentiation (GO:0046530) | 6.62434026 |
| 19 | sarcomere organization (GO:0045214) | 6.47688612 |
| 20 | retina development in camera-type eye (GO:0060041) | 6.46493343 |
| 21 | regulation of relaxation of muscle (GO:1901077) | 6.38788789 |
| 22 | myofibril assembly (GO:0030239) | 6.36086151 |
| 23 | striated muscle contraction (GO:0006941) | 6.31526017 |
| 24 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.22020605 |
| 25 | actin filament-based movement (GO:0030048) | 6.20400187 |
| 26 | creatine metabolic process (GO:0006600) | 6.19290244 |
| 27 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.95656363 |
| 28 | regulation of cGMP metabolic process (GO:0030823) | 5.93534355 |
| 29 | response to muscle activity (GO:0014850) | 5.88002444 |
| 30 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.60863962 |
| 31 | skeletal muscle adaptation (GO:0043501) | 5.52447615 |
| 32 | positive regulation of cGMP biosynthetic process (GO:0030828) | 5.50354915 |
| 33 | regulation of cGMP biosynthetic process (GO:0030826) | 5.14597357 |
| 34 | response to inactivity (GO:0014854) | 5.10375917 |
| 35 | NADH metabolic process (GO:0006734) | 5.03865819 |
| 36 | cardiac myofibril assembly (GO:0055003) | 5.03266830 |
| 37 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.00565367 |
| 38 | skeletal muscle fiber development (GO:0048741) | 5.00265849 |
| 39 | glycogen catabolic process (GO:0005980) | 4.96232450 |
| 40 | nonmotile primary cilium assembly (GO:0035058) | 4.94894797 |
| 41 | adaptation of signaling pathway (GO:0023058) | 4.92914700 |
| 42 | cardiac muscle contraction (GO:0060048) | 4.87402777 |
| 43 | positive regulation of cGMP metabolic process (GO:0030825) | 4.86400435 |
| 44 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.86206265 |
| 45 | * cellular response to radiation (GO:0071478) | 4.80532974 |
| 46 | actomyosin structure organization (GO:0031032) | 4.73147124 |
| 47 | muscle contraction (GO:0006936) | 4.72916152 |
| 48 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.68060140 |
| 49 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.67373067 |
| 50 | estrogen biosynthetic process (GO:0006703) | 4.61334068 |
| 51 | glucan catabolic process (GO:0009251) | 4.58785529 |
| 52 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.54050415 |
| 53 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.49043916 |
| 54 | plasma membrane repair (GO:0001778) | 4.48750000 |
| 55 | glycogen biosynthetic process (GO:0005978) | 4.46120725 |
| 56 | glucan biosynthetic process (GO:0009250) | 4.46120725 |
| 57 | cardiac muscle hypertrophy (GO:0003300) | 4.45762186 |
| 58 | myotube cell development (GO:0014904) | 4.42549738 |
| 59 | cellular polysaccharide catabolic process (GO:0044247) | 4.34104821 |
| 60 | striated muscle hypertrophy (GO:0014897) | 4.33035459 |
| 61 | muscle system process (GO:0003012) | 4.24084858 |
| 62 | striated muscle adaptation (GO:0014888) | 4.20503757 |
| 63 | retina layer formation (GO:0010842) | 4.19710516 |
| 64 | sensory perception (GO:0007600) | 4.19631182 |
| 65 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.17659390 |
| 66 | * regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.15849431 |
| 67 | myoblast fusion (GO:0007520) | 4.12457593 |
| 68 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.03942705 |
| 69 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.03315119 |
| 70 | carnitine shuttle (GO:0006853) | 3.98014730 |
| 71 | regulation of actin filament-based movement (GO:1903115) | 3.97835049 |
| 72 | muscle fiber development (GO:0048747) | 3.91256720 |
| 73 | polysaccharide catabolic process (GO:0000272) | 3.90263454 |
| 74 | regulation of cell communication by electrical coupling (GO:0010649) | 3.89470198 |
| 75 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.87787978 |
| 76 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.84241289 |
| 77 | gluconeogenesis (GO:0006094) | 3.83972649 |
| 78 | * response to light stimulus (GO:0009416) | 3.83732653 |
| 79 | muscle hypertrophy (GO:0014896) | 3.83411372 |
| 80 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.77039166 |
| 81 | positive regulation of myotube differentiation (GO:0010831) | 3.76822919 |
| 82 | 2-oxoglutarate metabolic process (GO:0006103) | 3.75080095 |
| 83 | glycogen metabolic process (GO:0005977) | 3.74655254 |
| 84 | muscle cell fate commitment (GO:0042693) | 3.71744512 |
| 85 | skeletal muscle tissue development (GO:0007519) | 3.71738151 |
| 86 | muscle organ morphogenesis (GO:0048644) | 3.70745738 |
| 87 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.66887731 |
| 88 | cellular glucan metabolic process (GO:0006073) | 3.64823349 |
| 89 | glucan metabolic process (GO:0044042) | 3.64823349 |
| 90 | muscle cell cellular homeostasis (GO:0046716) | 3.62836045 |
| 91 | neuron development (GO:0048666) | 3.55325307 |
| 92 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.54549943 |
| 93 | tricarboxylic acid cycle (GO:0006099) | 3.53645568 |
| 94 | muscle tissue morphogenesis (GO:0060415) | 3.52241572 |
| 95 | striated muscle atrophy (GO:0014891) | 3.50268508 |
| 96 | muscle adaptation (GO:0043500) | 3.49870578 |
| 97 | hexose biosynthetic process (GO:0019319) | 3.48253170 |
| 98 | protein localization to synapse (GO:0035418) | 3.45712929 |
| 99 | protein prenylation (GO:0018342) | 3.44799789 |
| 100 | prenylation (GO:0097354) | 3.44799789 |
| 101 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.42860709 |
| 102 | positive regulation of neurotransmitter transport (GO:0051590) | 3.40630550 |
| 103 | cardiac muscle cell development (GO:0055013) | 3.38998850 |
| 104 | membrane hyperpolarization (GO:0060081) | 3.38907479 |
| 105 | muscle organ development (GO:0007517) | 3.38187410 |
| 106 | skeletal muscle tissue regeneration (GO:0043403) | 3.37556809 |
| 107 | adult heart development (GO:0007512) | 3.36653431 |
| 108 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.36368580 |
| 109 | behavioral response to ethanol (GO:0048149) | 3.36297689 |
| 110 | muscle structure development (GO:0061061) | 3.35840453 |
| 111 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.34575506 |
| 112 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.33980258 |
| 113 | muscle hypertrophy in response to stress (GO:0003299) | 3.33980258 |
| 114 | cardiac muscle adaptation (GO:0014887) | 3.33980258 |
| 115 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.28789094 |
| 116 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.28367552 |
| 117 | carnitine transmembrane transport (GO:1902603) | 3.27287579 |
| 118 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.23468744 |
| 119 | fructose metabolic process (GO:0006000) | 3.21955394 |
| 120 | biotin metabolic process (GO:0006768) | 3.20127782 |
| 121 | monosaccharide biosynthetic process (GO:0046364) | 3.15879954 |
| 122 | retinoid metabolic process (GO:0001523) | 3.15546479 |
| 123 | striated muscle cell development (GO:0055002) | 3.14991497 |
| 124 | negative regulation of cell size (GO:0045792) | 3.14752560 |
| 125 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.13821720 |
| 126 | cardiac cell development (GO:0055006) | 3.13325120 |
| 127 | lipid translocation (GO:0034204) | 3.09897634 |
| 128 | phospholipid translocation (GO:0045332) | 3.09897634 |
| 129 | response to histamine (GO:0034776) | 3.09625239 |
| 130 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.07585273 |
| 131 | regulation of the force of heart contraction (GO:0002026) | 3.07248436 |
| 132 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.05717676 |
| 133 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.05717676 |
| 134 | regulation of penile erection (GO:0060405) | 3.05281487 |
| 135 | fatty acid transmembrane transport (GO:1902001) | 3.05210523 |
| 136 | muscle atrophy (GO:0014889) | 3.05024277 |
| 137 | retina homeostasis (GO:0001895) | 3.03620026 |
| 138 | regulation of striated muscle contraction (GO:0006942) | 3.01912967 |
| 139 | short-term memory (GO:0007614) | 3.01858972 |
| 140 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.98454014 |
| 141 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.98155078 |
| 142 | IMP metabolic process (GO:0046040) | 2.97867502 |
| 143 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.96306492 |
| 144 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.94955038 |
| 145 | carnitine transport (GO:0015879) | 2.93983689 |
| 146 | amino-acid betaine transport (GO:0015838) | 2.93983689 |
| 147 | post-embryonic morphogenesis (GO:0009886) | 2.92872995 |
| 148 | positive regulation of cation channel activity (GO:2001259) | 2.92101615 |
| 149 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.91218372 |
| 150 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.91218372 |
| 151 | diterpenoid metabolic process (GO:0016101) | 2.90999987 |
| 152 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.90617341 |
| 153 | oxaloacetate metabolic process (GO:0006107) | 2.90087409 |
| 154 | myotube differentiation (GO:0014902) | 2.89661690 |
| 155 | axoneme assembly (GO:0035082) | 2.86995774 |
| 156 | response to activity (GO:0014823) | 2.86101639 |
| 157 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.85648484 |
| 158 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.85214790 |
| 159 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.84988189 |
| 160 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.84664134 |
| 161 | syncytium formation (GO:0006949) | 2.84493004 |
| 162 | ubiquinone biosynthetic process (GO:0006744) | 2.83945607 |
| 163 | regulation of myoblast differentiation (GO:0045661) | 2.83332668 |
| 164 | regulation of sequestering of triglyceride (GO:0010889) | 2.83124127 |
| 165 | chemosensory behavior (GO:0007635) | 2.83037483 |
| 166 | response to pheromone (GO:0019236) | 2.72716365 |
| 167 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.70158727 |
| 168 | synaptic vesicle maturation (GO:0016188) | 2.69982157 |
| 169 | * response to radiation (GO:0009314) | 2.66363839 |
| 170 | terpenoid metabolic process (GO:0006721) | 2.64865299 |
| 171 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.64261643 |
| 172 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.63319168 |
| 173 | mitochondrion transport along microtubule (GO:0047497) | 2.63319168 |
| 174 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.60324994 |
| 175 | startle response (GO:0001964) | 2.59285810 |
| 176 | righting reflex (GO:0060013) | 2.56331464 |
| 177 | cellular potassium ion homeostasis (GO:0030007) | 2.53844196 |
| 178 | dopamine receptor signaling pathway (GO:0007212) | 2.49242736 |
| 179 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.48367450 |
| 180 | retinol metabolic process (GO:0042572) | 2.40044102 |
| 181 | histone H3-K4 trimethylation (GO:0080182) | 2.39827909 |
| 182 | negative regulation of cation channel activity (GO:2001258) | 2.39196355 |
| 183 | * cellular response to abiotic stimulus (GO:0071214) | 2.39141610 |
| 184 | protein heterotetramerization (GO:0051290) | 2.38455012 |
| 185 | establishment of mitochondrion localization (GO:0051654) | 2.35818079 |
| 186 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.35686545 |
| 187 | behavioral response to cocaine (GO:0048148) | 2.33362206 |
| 188 | icosanoid secretion (GO:0032309) | 2.33190332 |
| 189 | * regulation of rhodopsin mediated signaling pathway (GO:0022400) | 17.7863830 |
| 190 | * rhodopsin mediated signaling pathway (GO:0016056) | 17.5549183 |
| 191 | retinal cone cell development (GO:0046549) | 15.3861578 |
| 192 | photoreceptor cell maintenance (GO:0045494) | 12.2754864 |
| 193 | photoreceptor cell development (GO:0042461) | 11.9582806 |
| 194 | eye photoreceptor cell development (GO:0042462) | 11.3999024 |
| 195 | protein-chromophore linkage (GO:0018298) | 10.8154241 |
| 196 | * phototransduction, visible light (GO:0007603) | 10.4775924 |
| 197 | muscle filament sliding (GO:0030049) | 10.4516325 |
| 198 | actin-myosin filament sliding (GO:0033275) | 10.4516325 |
| 199 | * phototransduction (GO:0007602) | 10.3857966 |
| 200 | * detection of visible light (GO:0009584) | 10.0556488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.84162758 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.82279710 |
| 3 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 3.78770086 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.70613473 |
| 5 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.30030546 |
| 6 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.16517051 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.97750698 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.85821797 |
| 9 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.73688120 |
| 10 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.70197785 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.47031624 |
| 12 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.43948581 |
| 13 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.37954385 |
| 14 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.37954385 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.31947377 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.30606416 |
| 17 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.30576174 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.25943202 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 2.23478327 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.20919448 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.18404874 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.15855279 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.15645818 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.11435481 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.10422425 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.05415964 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96234466 |
| 28 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.96011094 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92134991 |
| 30 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.88263539 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.87204043 |
| 32 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.81944768 |
| 33 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.80323972 |
| 34 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.79099430 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.78434381 |
| 36 | GATA1_19941826_ChIP-Seq_K562_Human | 1.78140042 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.76292452 |
| 38 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.75017958 |
| 39 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.75007102 |
| 40 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.71693263 |
| 41 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.70780157 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69350356 |
| 43 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.67970143 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.67768290 |
| 45 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.67153226 |
| 46 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.65525332 |
| 47 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.63409525 |
| 48 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62964747 |
| 49 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62864062 |
| 50 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.61275037 |
| 51 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.58779902 |
| 52 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.58436939 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57783166 |
| 54 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.57460270 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.56552115 |
| 56 | * AR_19668381_ChIP-Seq_PC3_Human | 1.54175896 |
| 57 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.54079251 |
| 58 | MYC_22102868_ChIP-Seq_BL_Human | 1.53656505 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.52834873 |
| 60 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.52481956 |
| 61 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.52358999 |
| 62 | P68_20966046_ChIP-Seq_HELA_Human | 1.52055099 |
| 63 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.50096233 |
| 64 | STAT3_23295773_ChIP-Seq_U87_Human | 1.49824902 |
| 65 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.48271011 |
| 66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48124232 |
| 67 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.47919771 |
| 68 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.46920330 |
| 69 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.45615308 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44442136 |
| 71 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.44339786 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43957084 |
| 73 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.43654121 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.43265127 |
| 75 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.43244865 |
| 76 | TBL1_22424771_ChIP-Seq_293T_Human | 1.42267368 |
| 77 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.41969716 |
| 78 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.41895098 |
| 79 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.41186210 |
| 80 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.40842814 |
| 81 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.40794199 |
| 82 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.40625931 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.40206482 |
| 84 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.39262925 |
| 85 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.38565907 |
| 86 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.38294881 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37852930 |
| 88 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.36708022 |
| 89 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.36518539 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36117656 |
| 91 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35923368 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34956767 |
| 93 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.34571982 |
| 94 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.33713034 |
| 95 | ATF3_27146783_Chip-Seq_COLON_Human | 1.31720481 |
| 96 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31372166 |
| 97 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31256859 |
| 98 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30385264 |
| 99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29793710 |
| 100 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29690485 |
| 101 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.28921148 |
| 102 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28636186 |
| 103 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.27607694 |
| 104 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27393560 |
| 105 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.26822689 |
| 106 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25707178 |
| 107 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.24434521 |
| 108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24074346 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23955559 |
| 110 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22438292 |
| 111 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22388766 |
| 112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22369177 |
| 113 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.22214539 |
| 114 | TCF4_23295773_ChIP-Seq_U87_Human | 1.22002574 |
| 115 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21962877 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21886286 |
| 117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21231448 |
| 118 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.21118302 |
| 119 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.20837788 |
| 120 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.20429277 |
| 121 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20029028 |
| 122 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.19342529 |
| 123 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19233306 |
| 124 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19032264 |
| 125 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18523181 |
| 126 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17893971 |
| 127 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.16094869 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15817944 |
| 129 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15108840 |
| 130 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.13719640 |
| 131 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.12317868 |
| 132 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.12317868 |
| 133 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.11967567 |
| 134 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11247530 |
| 135 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10843039 |
| 136 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10567285 |
| 137 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.09707407 |
| 138 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.09380526 |
| 139 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.09201011 |
| 140 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08874762 |
| 141 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08242079 |
| 142 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07916769 |
| 143 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07882714 |
| 144 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07854371 |
| 145 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06899535 |
| 146 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06611075 |
| 147 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.05659416 |
| 148 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.05594635 |
| 149 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05469946 |
| 150 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05033130 |
| 151 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.04955949 |
| 152 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04624177 |
| 153 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04387979 |
| 154 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04326329 |
| 155 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03913823 |
| 156 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.03863939 |
| 157 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02437889 |
| 158 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.01843961 |
| 159 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01341718 |
| 160 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00698000 |
| 161 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00539515 |
| 162 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.00058543 |
| 163 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00048827 |
| 164 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99975428 |
| 165 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99975428 |
| 166 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99916944 |
| 167 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99595618 |
| 168 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99562292 |
| 169 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99502606 |
| 170 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99396434 |
| 171 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98771011 |
| 172 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.98068412 |
| 173 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97153591 |
| 174 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96923861 |
| 175 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96815754 |
| 176 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96539666 |
| 177 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96357823 |
| 178 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96136036 |
| 179 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95823251 |
| 180 | CBP_21632823_ChIP-Seq_H3396_Human | 0.95730102 |
| 181 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95605444 |
| 182 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.94886305 |
| 183 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94481679 |
| 184 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.93169573 |
| 185 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92352653 |
| 186 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92028925 |
| 187 | FUS_26573619_Chip-Seq_HEK293_Human | 0.91450699 |
| 188 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.91224948 |
| 189 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89518758 |
| 190 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89224628 |
| 191 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89188160 |
| 192 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.88873515 |
| 193 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88666752 |
| 194 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88002080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 9.72326109 |
| 2 | * MP0005253_abnormal_eye_physiology | 6.47313572 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.32866305 |
| 4 | MP0000751_myopathy | 5.26519549 |
| 5 | MP0005451_abnormal_body_composition | 4.38551731 |
| 6 | MP0003950_abnormal_plasma_membrane | 4.05033883 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.93059697 |
| 8 | MP0005195_abnormal_posterior_eye | 3.85056299 |
| 9 | MP0001324_abnormal_eye_pigmentation | 3.62311278 |
| 10 | MP0000747_muscle_weakness | 3.35324792 |
| 11 | MP0002090_abnormal_vision | 3.29819283 |
| 12 | MP0004087_abnormal_muscle_fiber | 3.24503706 |
| 13 | MP0000759_abnormal_skeletal_muscle | 3.22501136 |
| 14 | MP0002106_abnormal_muscle_physiology | 3.15303902 |
| 15 | * MP0005391_vision/eye_phenotype | 3.13236891 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.91043416 |
| 17 | MP0002269_muscular_atrophy | 2.86905551 |
| 18 | MP0004130_abnormal_muscle_cell | 2.82751563 |
| 19 | MP0000750_abnormal_muscle_regeneration | 2.74842526 |
| 20 | MP0002638_abnormal_pupillary_reflex | 2.70126254 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.69708755 |
| 22 | MP0002229_neurodegeneration | 2.66299421 |
| 23 | MP0005369_muscle_phenotype | 2.64603413 |
| 24 | MP0000733_abnormal_muscle_development | 2.13282636 |
| 25 | MP0003011_delayed_dark_adaptation | 11.1977939 |
| 26 | MP0001764_abnormal_homeostasis | 1.99294829 |
| 27 | MP0002752_abnormal_somatic_nervous | 1.93992605 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.90912245 |
| 29 | MP0004185_abnormal_adipocyte_glucose | 1.89191126 |
| 30 | MP0002972_abnormal_cardiac_muscle | 1.87234854 |
| 31 | MP0010630_abnormal_cardiac_muscle | 1.76235941 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.74563461 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.73082518 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.66164310 |
| 35 | MP0002822_catalepsy | 1.54046743 |
| 36 | MP0004484_altered_response_of | 1.49405069 |
| 37 | MP0004019_abnormal_vitamin_homeostasis | 1.47638965 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.46125397 |
| 39 | MP0001348_abnormal_lacrimal_gland | 1.44462829 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.40961227 |
| 41 | MP0010030_abnormal_orbit_morphology | 1.40949536 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.39698582 |
| 43 | MP0006138_congestive_heart_failure | 1.38648734 |
| 44 | MP0004233_abnormal_muscle_weight | 1.37706915 |
| 45 | MP0006292_abnormal_olfactory_placode | 1.27543701 |
| 46 | MP0005083_abnormal_biliary_tract | 1.24977677 |
| 47 | MP0005375_adipose_tissue_phenotype | 1.23300339 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.21463581 |
| 49 | MP0004147_increased_porphyrin_level | 1.18590319 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.18204867 |
| 51 | MP0003221_abnormal_cardiomyocyte_apopto | 1.17320879 |
| 52 | MP0001544_abnormal_cardiovascular_syste | 1.16103545 |
| 53 | MP0005385_cardiovascular_system_phenoty | 1.16103545 |
| 54 | MP0000003_abnormal_adipose_tissue | 1.15547104 |
| 55 | MP0004510_myositis | 1.15131949 |
| 56 | MP0005266_abnormal_metabolism | 1.10635686 |
| 57 | MP0005670_abnormal_white_adipose | 1.10551062 |
| 58 | MP0001984_abnormal_olfaction | 1.10386879 |
| 59 | MP0001486_abnormal_startle_reflex | 1.08495935 |
| 60 | MP0002971_abnormal_brown_adipose | 1.07311220 |
| 61 | MP0008775_abnormal_heart_ventricle | 1.03787892 |
| 62 | MP0004885_abnormal_endolymph | 0.98101983 |
| 63 | MP0004270_analgesia | 0.96561923 |
| 64 | MP0005197_abnormal_uvea_morphology | 0.93021689 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 0.92179395 |
| 66 | MP0002332_abnormal_exercise_endurance | 0.79007348 |
| 67 | MP0003880_abnormal_central_pattern | 0.78556391 |
| 68 | MP0005394_taste/olfaction_phenotype | 0.75815713 |
| 69 | MP0005499_abnormal_olfactory_system | 0.75815713 |
| 70 | MP0003137_abnormal_impulse_conducting | 0.74252809 |
| 71 | MP0003878_abnormal_ear_physiology | 0.74120658 |
| 72 | MP0005377_hearing/vestibular/ear_phenot | 0.74120658 |
| 73 | MP0002127_abnormal_cardiovascular_syste | 0.74098690 |
| 74 | MP0002272_abnormal_nervous_system | 0.70163638 |
| 75 | MP0003634_abnormal_glial_cell | 0.69487852 |
| 76 | MP0000266_abnormal_heart_morphology | 0.67991496 |
| 77 | MP0005058_abnormal_lysosome_morphology | 0.66412581 |
| 78 | MP0009046_muscle_twitch | 0.63548867 |
| 79 | MP0001286_abnormal_eye_development | 0.63329538 |
| 80 | MP0002249_abnormal_larynx_morphology | 0.62209979 |
| 81 | MP0002064_seizures | 0.60877834 |
| 82 | MP0009672_abnormal_birth_weight | 0.59582891 |
| 83 | MP0002734_abnormal_mechanical_nocicepti | 0.59559127 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 0.59517950 |
| 85 | MP0001963_abnormal_hearing_physiology | 0.59286943 |
| 86 | MP0002877_abnormal_melanocyte_morpholog | 0.58343882 |
| 87 | MP0004134_abnormal_chest_morphology | 0.57899238 |
| 88 | MP0008004_abnormal_stomach_pH | 0.57695267 |
| 89 | MP0008789_abnormal_olfactory_epithelium | 0.57477614 |
| 90 | MP0003635_abnormal_synaptic_transmissio | 0.56594363 |
| 91 | MP0004859_abnormal_synaptic_plasticity | 0.54414264 |
| 92 | MP0000372_irregular_coat_pigmentation | 0.54179578 |
| 93 | MP0001346_abnormal_lacrimal_gland | 0.53324304 |
| 94 | MP0004858_abnormal_nervous_system | 0.53223362 |
| 95 | MP0003828_pulmonary_edema | 0.52387735 |
| 96 | MP0005187_abnormal_penis_morphology | 0.51512586 |
| 97 | MP0000534_abnormal_ureter_morphology | 0.50744229 |
| 98 | MP0003959_abnormal_lean_body | 0.50538266 |
| 99 | MP0005410_abnormal_fertilization | 0.49960195 |
| 100 | MP0002067_abnormal_sensory_capabilities | 0.48606841 |
| 101 | MP0001968_abnormal_touch/_nociception | 0.48580632 |
| 102 | MP0002114_abnormal_axial_skeleton | 0.48506046 |
| 103 | MP0002572_abnormal_emotion/affect_behav | 0.48229905 |
| 104 | MP0005334_abnormal_fat_pad | 0.47038633 |
| 105 | MP0002063_abnormal_learning/memory/cond | 0.46243445 |
| 106 | MP0000762_abnormal_tongue_morphology | 0.45107914 |
| 107 | MP0005386_behavior/neurological_phenoty | 0.43850400 |
| 108 | MP0004924_abnormal_behavior | 0.43850400 |
| 109 | MP0004215_abnormal_myocardial_fiber | 0.43099699 |
| 110 | MP0002078_abnormal_glucose_homeostasis | 0.42413661 |
| 111 | MP0002128_abnormal_blood_circulation | 0.42018599 |
| 112 | MP0002896_abnormal_bone_mineralization | 0.41861648 |
| 113 | MP0008260_abnormal_autophagy | 0.41725123 |
| 114 | MP0004742_abnormal_vestibular_system | 0.41257781 |
| 115 | MP0003045_fibrosis | 0.41184221 |
| 116 | MP0000631_abnormal_neuroendocrine_gland | 0.40892620 |
| 117 | MP0000467_abnormal_esophagus_morphology | 0.40888976 |
| 118 | MP0009745_abnormal_behavioral_response | 0.40698137 |
| 119 | MP0004808_abnormal_hematopoietic_stem | 0.40642078 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.39167361 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.38925464 |
| 122 | MP0003890_abnormal_embryonic-extraembry | 0.37557139 |
| 123 | MP0002102_abnormal_ear_morphology | 0.37268782 |
| 124 | MP0005452_abnormal_adipose_tissue | 0.36955933 |
| 125 | MP0009250_abnormal_appendicular_skeleto | 0.36815383 |
| 126 | MP0005646_abnormal_pituitary_gland | 0.35625166 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.34805440 |
| 128 | MP0010386_abnormal_urinary_bladder | 0.34695711 |
| 129 | MP0004197_abnormal_fetal_growth/weight/ | 0.32882689 |
| 130 | MP0001188_hyperpigmentation | 0.32794812 |
| 131 | MP0006035_abnormal_mitochondrial_morpho | 0.32576986 |
| 132 | MP0005248_abnormal_Harderian_gland | 0.32517138 |
| 133 | MP0003948_abnormal_gas_homeostasis | 0.30709309 |
| 134 | MP0005171_absent_coat_pigmentation | 0.30667243 |
| 135 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.30538737 |
| 136 | MP0000026_abnormal_inner_ear | 0.30037390 |
| 137 | MP0003566_abnormal_cell_adhesion | 0.30015948 |
| 138 | MP0004085_abnormal_heartbeat | 0.29721859 |
| 139 | MP0002697_abnormal_eye_size | 0.29650568 |
| 140 | MP0008569_lethality_at_weaning | 0.29111788 |
| 141 | MP0009703_decreased_birth_body | 0.29002334 |
| 142 | MP0002009_preneoplasia | 0.27915389 |
| 143 | MP0008874_decreased_physiological_sensi | 0.27758276 |
| 144 | MP0004782_abnormal_surfactant_physiolog | 0.26698114 |
| 145 | MP0004142_abnormal_muscle_tone | 0.25960150 |
| 146 | MP0005535_abnormal_body_temperature | 0.25584502 |
| 147 | MP0002152_abnormal_brain_morphology | 0.25260266 |
| 148 | MP0005620_abnormal_muscle_contractility | 0.25182798 |
| 149 | MP0003943_abnormal_hepatobiliary_system | 0.25166038 |
| 150 | MP0002184_abnormal_innervation | 0.25103059 |
| 151 | MP0002928_abnormal_bile_duct | 0.24517805 |
| 152 | MP0009780_abnormal_chondrocyte_physiolo | 0.24324544 |
| 153 | MP0002066_abnormal_motor_capabilities/c | 0.22846935 |
| 154 | MP0001915_intracranial_hemorrhage | 0.22630317 |
| 155 | MP0003646_muscle_fatigue | 0.22535060 |
| 156 | MP0000778_abnormal_nervous_system | 0.21427789 |
| 157 | MP0010368_abnormal_lymphatic_system | 0.19660969 |
| 158 | MP0004145_abnormal_muscle_electrophysio | 0.18554659 |
| 159 | MP0004811_abnormal_neuron_physiology | 0.17749981 |
| 160 | MP0002557_abnormal_social/conspecific_i | 0.17299460 |
| 161 | MP0004043_abnormal_pH_regulation | 0.16117827 |
| 162 | MP0005193_abnormal_anterior_eye | 0.15513692 |
| 163 | MP0001879_abnormal_lymphatic_vessel | 0.15377905 |
| 164 | MP0005595_abnormal_vascular_smooth | 0.14545491 |
| 165 | MP0000749_muscle_degeneration | 0.14502849 |
| 166 | MP0005330_cardiomyopathy | 0.14362755 |
| 167 | MP0002108_abnormal_muscle_morphology | 0.13995266 |
| 168 | MP0001293_anophthalmia | 0.13533248 |
| 169 | MP0000569_abnormal_digit_pigmentation | 0.13296898 |
| 170 | MP0001661_extended_life_span | 0.11473025 |
| 171 | MP0003252_abnormal_bile_duct | 0.11227390 |
| 172 | MP0001970_abnormal_pain_threshold | 0.10917319 |
| 173 | MP0003632_abnormal_nervous_system | 0.10897675 |
| 174 | MP0002909_abnormal_adrenal_gland | 0.10793645 |
| 175 | MP0003879_abnormal_hair_cell | 0.10241717 |
| 176 | MP0005076_abnormal_cell_differentiation | 0.09984319 |
| 177 | MP0010770_preweaning_lethality | 0.09273100 |
| 178 | MP0002082_postnatal_lethality | 0.09273100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 9.97907404 |
| 2 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 9.90464227 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.77848920 |
| 4 | Abnormal rod and cone electroretinograms (HP:0008323) | 9.52006107 |
| 5 | Central scotoma (HP:0000603) | 9.17727364 |
| 6 | Dyschromatopsia (HP:0007641) | 9.04033388 |
| 7 | Abnormality of macular pigmentation (HP:0008002) | 8.47214525 |
| 8 | Pigmentary retinal degeneration (HP:0001146) | 8.41253978 |
| 9 | Scotoma (HP:0000575) | 8.16784658 |
| 10 | Chorioretinal atrophy (HP:0000533) | 8.09220398 |
| 11 | Exercise-induced myalgia (HP:0003738) | 8.04019320 |
| 12 | Attenuation of retinal blood vessels (HP:0007843) | 7.67285386 |
| 13 | Pendular nystagmus (HP:0012043) | 7.54575864 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 7.40229871 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 6.87913574 |
| 16 | Abolished electroretinogram (ERG) (HP:0000550) | 6.53083801 |
| 17 | Decreased central vision (HP:0007663) | 6.33407724 |
| 18 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.04642651 |
| 19 | Myopathic facies (HP:0002058) | 5.59368778 |
| 20 | Calf muscle hypertrophy (HP:0008981) | 5.56377504 |
| 21 | Type II diabetes mellitus (HP:0005978) | 5.55436070 |
| 22 | * Photophobia (HP:0000613) | 5.54892431 |
| 23 | Distal arthrogryposis (HP:0005684) | 5.13339388 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 5.05536318 |
| 25 | Cone-rod dystrophy (HP:0000548) | 5.01732533 |
| 26 | Macular degeneration (HP:0000608) | 4.97790333 |
| 27 | Hyporeflexia of lower limbs (HP:0002600) | 4.96196998 |
| 28 | Posterior subcapsular cataract (HP:0007787) | 4.95240607 |
| 29 | Severe visual impairment (HP:0001141) | 4.94478323 |
| 30 | Rhabdomyolysis (HP:0003201) | 4.85366083 |
| 31 | Myoglobinuria (HP:0002913) | 4.81771909 |
| 32 | Increased corneal curvature (HP:0100692) | 4.75247143 |
| 33 | Keratoconus (HP:0000563) | 4.75247143 |
| 34 | Choroideremia (HP:0001139) | 4.70180897 |
| 35 | Vitreoretinal degeneration (HP:0000655) | 4.64428879 |
| 36 | Constricted visual fields (HP:0001133) | 4.52097760 |
| 37 | Abnormality of the calf musculature (HP:0001430) | 4.42432736 |
| 38 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.41865865 |
| 39 | Muscle fiber splitting (HP:0003555) | 4.39482895 |
| 40 | Retinitis pigmentosa (HP:0000510) | 4.36928331 |
| 41 | Round ear (HP:0100830) | 4.32880572 |
| 42 | Neck muscle weakness (HP:0000467) | 4.22903392 |
| 43 | Ulnar deviation of the wrist (HP:0003049) | 4.18486127 |
| 44 | Rimmed vacuoles (HP:0003805) | 4.06448768 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 4.06402858 |
| 46 | Subaortic stenosis (HP:0001682) | 4.06227378 |
| 47 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.06227378 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 4.03005929 |
| 49 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.01405555 |
| 50 | Difficulty running (HP:0009046) | 3.96015822 |
| 51 | Increased connective tissue (HP:0009025) | 3.86248496 |
| 52 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.65922178 |
| 53 | Calcaneovalgus deformity (HP:0001848) | 3.64517417 |
| 54 | Muscle stiffness (HP:0003552) | 3.51257694 |
| 55 | Increased variability in muscle fiber diameter (HP:0003557) | 3.43132813 |
| 56 | Sudden death (HP:0001699) | 3.29682466 |
| 57 | Areflexia of lower limbs (HP:0002522) | 3.29435435 |
| 58 | Progressive visual loss (HP:0000529) | 3.28291298 |
| 59 | Retinal atrophy (HP:0001105) | 3.27316816 |
| 60 | Absent phalangeal crease (HP:0006109) | 3.14451116 |
| 61 | Bundle branch block (HP:0011710) | 3.13911465 |
| 62 | Deformed tarsal bones (HP:0008119) | 3.13616892 |
| 63 | Congenital sensorineural hearing impairment (HP:0008527) | 3.13089995 |
| 64 | Subcapsular cataract (HP:0000523) | 3.10121057 |
| 65 | Frequent falls (HP:0002359) | 3.07702867 |
| 66 | Progressive muscle weakness (HP:0003323) | 2.95212848 |
| 67 | EMG: neuropathic changes (HP:0003445) | 2.93836088 |
| 68 | Distal lower limb amyotrophy (HP:0008944) | 2.86516402 |
| 69 | Ventricular tachycardia (HP:0004756) | 2.73912395 |
| 70 | Myotonia (HP:0002486) | 2.67349679 |
| 71 | Malignant hyperthermia (HP:0002047) | 2.63476636 |
| 72 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.62198218 |
| 73 | Bulbar palsy (HP:0001283) | 2.59933174 |
| 74 | Hyperkalemia (HP:0002153) | 2.59628370 |
| 75 | Generalized muscle weakness (HP:0003324) | 2.59064930 |
| 76 | Optic disc pallor (HP:0000543) | 2.56878597 |
| 77 | Dilated cardiomyopathy (HP:0001644) | 2.56102843 |
| 78 | Abnormal finger flexion creases (HP:0006143) | 2.53437703 |
| 79 | Abnormality of the calcaneus (HP:0008364) | 2.49789883 |
| 80 | Wide nasal bridge (HP:0000431) | 2.48588718 |
| 81 | Lipoatrophy (HP:0100578) | 2.41769172 |
| 82 | Difficulty climbing stairs (HP:0003551) | 2.41052966 |
| 83 | Scapular winging (HP:0003691) | 2.35848110 |
| 84 | Abnormality of the foot musculature (HP:0001436) | 2.30168473 |
| 85 | Foot dorsiflexor weakness (HP:0009027) | 2.27910831 |
| 86 | Spinal rigidity (HP:0003306) | 2.27878364 |
| 87 | Gait imbalance (HP:0002141) | 2.24024031 |
| 88 | Congenital primary aphakia (HP:0007707) | 2.22454112 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 2.16922035 |
| 90 | Paralysis (HP:0003470) | 2.12775050 |
| 91 | Lower limb amyotrophy (HP:0007210) | 2.11985474 |
| 92 | Limb-girdle muscle atrophy (HP:0003797) | 2.07576784 |
| 93 | Diaphragmatic weakness (HP:0009113) | 2.07343640 |
| 94 | Nephrogenic diabetes insipidus (HP:0009806) | 2.00641759 |
| 95 | Congenital stationary night blindness (HP:0007642) | 14.5453127 |
| 96 | Bony spicule pigmentary retinopathy (HP:0007737) | 12.0030446 |
| 97 | Muscle fiber inclusion bodies (HP:0100299) | 10.1550659 |
| 98 | Slender build (HP:0001533) | 1.98918006 |
| 99 | Muscular dystrophy (HP:0003560) | 1.96292881 |
| 100 | Fetal akinesia sequence (HP:0001989) | 1.95679685 |
| 101 | Medial flaring of the eyebrow (HP:0010747) | 1.93796047 |
| 102 | Achilles tendon contracture (HP:0001771) | 1.89940693 |
| 103 | Gowers sign (HP:0003391) | 1.89588212 |
| 104 | Reticulocytosis (HP:0001923) | 1.88796096 |
| 105 | Weak cry (HP:0001612) | 1.86288572 |
| 106 | Waddling gait (HP:0002515) | 1.85547090 |
| 107 | Fatigable weakness (HP:0003473) | 1.85287999 |
| 108 | Abnormality of the neuromuscular junction (HP:0003398) | 1.85287999 |
| 109 | Abnormality of the tricuspid valve (HP:0001702) | 1.85248303 |
| 110 | Abnormal atrioventricular conduction (HP:0005150) | 1.84666219 |
| 111 | Heart block (HP:0012722) | 1.84422135 |
| 112 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.79023678 |
| 113 | Proximal amyotrophy (HP:0007126) | 1.78115638 |
| 114 | Horizontal nystagmus (HP:0000666) | 1.75797842 |
| 115 | Poor coordination (HP:0002370) | 1.72738636 |
| 116 | Pelvic girdle muscle weakness (HP:0003749) | 1.69221988 |
| 117 | Shoulder girdle muscle weakness (HP:0003547) | 1.67982465 |
| 118 | Polar cataract (HP:0010696) | 1.67564517 |
| 119 | Cholelithiasis (HP:0001081) | 1.64573176 |
| 120 | Hip contracture (HP:0003273) | 1.64469072 |
| 121 | Abnormality of the Achilles tendon (HP:0005109) | 1.62791874 |
| 122 | Exercise intolerance (HP:0003546) | 1.62358242 |
| 123 | Steppage gait (HP:0003376) | 1.59849735 |
| 124 | Optic atrophy (HP:0000648) | 1.59790406 |
| 125 | Long clavicles (HP:0000890) | 1.58950406 |
| 126 | Epileptic encephalopathy (HP:0200134) | 1.57274068 |
| 127 | Limb-girdle muscle weakness (HP:0003325) | 1.57094291 |
| 128 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.56916193 |
| 129 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.56629632 |
| 130 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.56629632 |
| 131 | Metatarsus adductus (HP:0001840) | 1.55647907 |
| 132 | Febrile seizures (HP:0002373) | 1.53425800 |
| 133 | Vaginal atresia (HP:0000148) | 1.53408480 |
| 134 | Ventricular arrhythmia (HP:0004308) | 1.53022868 |
| 135 | Hyperthyroidism (HP:0000836) | 1.51868590 |
| 136 | True hermaphroditism (HP:0010459) | 1.48594950 |
| 137 | Increased intramyocellular lipid droplets (HP:0012240) | 1.48320056 |
| 138 | Genital tract atresia (HP:0001827) | 1.47548594 |
| 139 | Pancreatic fibrosis (HP:0100732) | 1.46894788 |
| 140 | Bowel incontinence (HP:0002607) | 1.45299626 |
| 141 | Dysmetric saccades (HP:0000641) | 1.45222926 |
| 142 | Stridor (HP:0010307) | 1.43355967 |
| 143 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.42419325 |
| 144 | Increased muscle lipid content (HP:0009058) | 1.39741998 |
| 145 | Abnormal large intestine physiology (HP:0012700) | 1.38849526 |
| 146 | Hyperuricemia (HP:0002149) | 1.38608421 |
| 147 | Increased purine levels (HP:0004368) | 1.38608421 |
| 148 | Severe Myopia (HP:0011003) | 1.37117886 |
| 149 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.31592316 |
| 150 | Interstitial pulmonary disease (HP:0006530) | 1.30440906 |
| 151 | Astigmatism (HP:0000483) | 1.27527356 |
| 152 | Dysdiadochokinesis (HP:0002075) | 1.27344545 |
| 153 | Retinal detachment (HP:0000541) | 1.26219265 |
| 154 | Hypoplasia of the fovea (HP:0007750) | 1.25421425 |
| 155 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.25421425 |
| 156 | Abnormality of the fovea (HP:0000493) | 1.25411673 |
| 157 | Pancreatic cysts (HP:0001737) | 1.20268361 |
| 158 | Cystic liver disease (HP:0006706) | 1.15159426 |
| 159 | Truncal ataxia (HP:0002078) | 1.09466211 |
| 160 | Progressive cerebellar ataxia (HP:0002073) | 1.08690581 |
| 161 | Chorioretinal coloboma (HP:0000567) | 1.07047732 |
| 162 | Genetic anticipation (HP:0003743) | 1.04303362 |
| 163 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.02271265 |
| 164 | Chronic hepatic failure (HP:0100626) | 0.95277363 |
| 165 | Abnormality of the fingertips (HP:0001211) | 0.93068120 |
| 166 | Recurrent sinusitis (HP:0011108) | 0.92551864 |
| 167 | Abnormality of dental color (HP:0011073) | 0.92440946 |
| 168 | Aplasia/Hypoplasia of the macula (HP:0008059) | 0.91333275 |
| 169 | Prolonged QT interval (HP:0001657) | 0.91094711 |
| 170 | Broad foot (HP:0001769) | 0.90689757 |
| 171 | Specific learning disability (HP:0001328) | 0.90495754 |
| 172 | Sclerocornea (HP:0000647) | 0.89759666 |
| 173 | Hypermetropia (HP:0000540) | 0.89096048 |
| 174 | Left ventricular hypertrophy (HP:0001712) | 0.88653098 |
| 175 | Molar tooth sign on MRI (HP:0002419) | 0.87340779 |
| 176 | Abnormality of midbrain morphology (HP:0002418) | 0.87340779 |
| 177 | Broad-based gait (HP:0002136) | 0.82839542 |
| 178 | Decreased testicular size (HP:0008734) | 0.82778441 |
| 179 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.82753063 |
| 180 | Visual hallucinations (HP:0002367) | 0.82522959 |
| 181 | Asthma (HP:0002099) | 0.81067671 |
| 182 | Furrowed tongue (HP:0000221) | 0.79129656 |
| 183 | Cerebellar dysplasia (HP:0007033) | 0.78981615 |
| 184 | Anencephaly (HP:0002323) | 0.76079910 |
| 185 | Lymphopenia (HP:0001888) | 0.74491669 |
| 186 | Abnormal EKG (HP:0003115) | 0.73734106 |
| 187 | Gaze-evoked nystagmus (HP:0000640) | 0.73608717 |
| 188 | Corneal dystrophy (HP:0001131) | 0.72021265 |
| 189 | Postaxial hand polydactyly (HP:0001162) | 0.72001794 |
| 190 | Nephronophthisis (HP:0000090) | 0.71254743 |
| 191 | Macroorchidism (HP:0000053) | 0.70676979 |
| 192 | Congenital hepatic fibrosis (HP:0002612) | 0.69771875 |
| 193 | Short foot (HP:0001773) | 0.68052171 |
| 194 | Hyperventilation (HP:0002883) | 0.67665088 |
| 195 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 0.67301779 |
| 196 | Postaxial foot polydactyly (HP:0001830) | 0.66469482 |
| 197 | Absent speech (HP:0001344) | 0.65803908 |
| 198 | Syncope (HP:0001279) | 0.65358380 |
| 199 | Dental crowding (HP:0000678) | 0.63297630 |
| 200 | Partial agenesis of the corpus callosum (HP:0001338) | 0.63258332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 9.37112545 |
| 2 | TTN | 5.89538265 |
| 3 | PBK | 4.88545657 |
| 4 | TRIB3 | 3.09573146 |
| 5 | PINK1 | 2.97947158 |
| 6 | MAP2K3 | 2.35466649 |
| 7 | SIK2 | 2.21384505 |
| 8 | EEF2K | 2.21225904 |
| 9 | PIK3CG | 2.02814299 |
| 10 | CDK12 | 2.02021542 |
| 11 | IRAK2 | 2.01481405 |
| 12 | GRK1 | 11.5491901 |
| 13 | CAMK1G | 1.85475132 |
| 14 | BRD4 | 1.76801289 |
| 15 | CAMK1D | 1.71593912 |
| 16 | MAPK7 | 1.62716664 |
| 17 | INSRR | 1.60212314 |
| 18 | MUSK | 1.53757079 |
| 19 | MAPK12 | 1.49695989 |
| 20 | ADRBK1 | 1.49604978 |
| 21 | AKT3 | 1.48207168 |
| 22 | MAPKAPK3 | 1.46103498 |
| 23 | TAOK3 | 1.43549010 |
| 24 | SGK2 | 1.34282562 |
| 25 | MAP3K4 | 1.31830999 |
| 26 | HIPK2 | 1.28663854 |
| 27 | STK38 | 1.28098457 |
| 28 | MAP3K10 | 1.24816465 |
| 29 | SGK223 | 1.13022003 |
| 30 | SGK494 | 1.13022003 |
| 31 | CSNK1D | 1.12358780 |
| 32 | MARK1 | 1.11563480 |
| 33 | IRAK3 | 1.10927264 |
| 34 | DMPK | 1.10315906 |
| 35 | SCYL2 | 1.09211973 |
| 36 | SGK3 | 1.07393294 |
| 37 | PAK6 | 1.06628684 |
| 38 | TRPM7 | 1.02637001 |
| 39 | MAP2K7 | 0.99748017 |
| 40 | TAOK2 | 0.96896755 |
| 41 | MAP3K11 | 0.96701020 |
| 42 | TTK | 0.95763337 |
| 43 | LATS1 | 0.94313406 |
| 44 | CDK3 | 0.90631226 |
| 45 | PRKCH | 0.89725688 |
| 46 | WNK1 | 0.89385705 |
| 47 | ERBB2 | 0.88337092 |
| 48 | MOS | 0.85141096 |
| 49 | CAMK2G | 0.85077542 |
| 50 | PNCK | 0.84137885 |
| 51 | SIK3 | 0.83684665 |
| 52 | RPS6KB2 | 0.81170384 |
| 53 | SMG1 | 0.78380585 |
| 54 | EIF2AK1 | 0.78334606 |
| 55 | RPS6KA4 | 0.77902196 |
| 56 | NME1 | 0.77351445 |
| 57 | PRKCZ | 0.74471199 |
| 58 | PRKCB | 0.73610493 |
| 59 | PRKAA2 | 0.73585962 |
| 60 | DYRK1A | 0.73245297 |
| 61 | PRKAA1 | 0.73209529 |
| 62 | PKN2 | 0.72757728 |
| 63 | PRPF4B | 0.72455063 |
| 64 | LATS2 | 0.72125330 |
| 65 | MTOR | 0.71011120 |
| 66 | CAMKK1 | 0.69897108 |
| 67 | CAMK1 | 0.69299678 |
| 68 | FES | 0.68936421 |
| 69 | CASK | 0.67362846 |
| 70 | PRKD3 | 0.67329729 |
| 71 | CDK9 | 0.66846685 |
| 72 | CAMK2D | 0.66416373 |
| 73 | NME2 | 0.64448195 |
| 74 | MAPK11 | 0.64377957 |
| 75 | RPS6KC1 | 0.63428595 |
| 76 | RPS6KL1 | 0.63428595 |
| 77 | ARAF | 0.60817356 |
| 78 | CAMK4 | 0.60405112 |
| 79 | PLK2 | 0.59382150 |
| 80 | MAP2K1 | 0.58780759 |
| 81 | SGK1 | 0.57472121 |
| 82 | RPS6KA3 | 0.56482721 |
| 83 | MAP2K6 | 0.56253655 |
| 84 | GRK5 | 0.56243886 |
| 85 | PDPK1 | 0.55146757 |
| 86 | GSK3B | 0.54501657 |
| 87 | ICK | 0.54076259 |
| 88 | YES1 | 0.53390625 |
| 89 | SIK1 | 0.52680685 |
| 90 | MAP2K2 | 0.52402565 |
| 91 | CHEK2 | 0.51919276 |
| 92 | PRKACG | 0.51409887 |
| 93 | TESK1 | 0.51245883 |
| 94 | LIMK1 | 0.51024680 |
| 95 | NEK9 | 0.50307573 |
| 96 | PRKD2 | 0.50231597 |
| 97 | MAPK14 | 0.49806141 |
| 98 | PRKDC | 0.49639813 |
| 99 | KSR2 | 0.49572920 |
| 100 | AKT2 | 0.49103906 |
| 101 | PLK4 | 0.48944681 |
| 102 | NEK1 | 0.48684020 |
| 103 | PKN1 | 0.47834843 |
| 104 | NEK2 | 0.47610656 |
| 105 | MAP3K7 | 0.47609160 |
| 106 | RPS6KA6 | 0.47476158 |
| 107 | BRAF | 0.47420696 |
| 108 | MYLK | 0.47387988 |
| 109 | MARK2 | 0.47313574 |
| 110 | CDK8 | 0.46669758 |
| 111 | ATR | 0.46640996 |
| 112 | MAP3K1 | 0.45874998 |
| 113 | RPS6KA2 | 0.45434361 |
| 114 | TAOK1 | 0.44588607 |
| 115 | MAPK10 | 0.44308339 |
| 116 | NUAK1 | 0.44085777 |
| 117 | DYRK1B | 0.43964538 |
| 118 | MAP3K3 | 0.43853594 |
| 119 | CDK1 | 0.43025088 |
| 120 | CDK5 | 0.42625599 |
| 121 | MST1R | 0.42470825 |
| 122 | MAPK4 | 0.42278646 |
| 123 | RPS6KA1 | 0.42164068 |
| 124 | MAP2K4 | 0.42155654 |
| 125 | EPHA2 | 0.41274207 |
| 126 | TNIK | 0.40921705 |
| 127 | NEK6 | 0.40309092 |
| 128 | PLK3 | 0.39553921 |
| 129 | MKNK2 | 0.38253332 |
| 130 | CAMK2B | 0.37890255 |
| 131 | MAPK9 | 0.37377928 |
| 132 | ATM | 0.35792465 |
| 133 | PDK2 | 0.35223688 |
| 134 | MAPK13 | 0.34442430 |
| 135 | RPS6KB1 | 0.34135915 |
| 136 | FRK | 0.33867217 |
| 137 | CCNB1 | 0.33864754 |
| 138 | TNK2 | 0.32677585 |
| 139 | PRKACA | 0.31968544 |
| 140 | CDK7 | 0.31726224 |
| 141 | STK11 | 0.31717267 |
| 142 | LRRK2 | 0.30796881 |
| 143 | TBK1 | 0.29996428 |
| 144 | NTRK3 | 0.29939996 |
| 145 | MAPK8 | 0.29207970 |
| 146 | CHEK1 | 0.28203073 |
| 147 | PHKG1 | 0.28180403 |
| 148 | PHKG2 | 0.28180403 |
| 149 | MAP3K8 | 0.27554403 |
| 150 | ILK | 0.27252868 |
| 151 | MAP3K6 | 0.26504284 |
| 152 | MINK1 | 0.26158929 |
| 153 | PRKCA | 0.25566530 |
| 154 | PRKCG | 0.25191436 |
| 155 | CSNK1E | 0.23880419 |
| 156 | ERBB3 | 0.23814095 |
| 157 | ROCK1 | 0.23593544 |
| 158 | TESK2 | 0.23473850 |
| 159 | ERN1 | 0.22679182 |
| 160 | PRKG1 | 0.21754306 |
| 161 | RIPK1 | 0.19884647 |
| 162 | PDK1 | 0.19535305 |
| 163 | CAMK2A | 0.17425649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.65233306 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.38148923 |
| 3 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.45520085 |
| 4 | Carbon metabolism_Homo sapiens_hsa01200 | 2.41672484 |
| 5 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.11210647 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 15.8904714 |
| 7 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.88535371 |
| 8 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.78218050 |
| 9 | Insulin resistance_Homo sapiens_hsa04931 | 1.69605866 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.61765891 |
| 11 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.59666566 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.56014022 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.46018874 |
| 14 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39057527 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.36123212 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.29063502 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.23416748 |
| 18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.15510045 |
| 19 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09673082 |
| 20 | Circadian rhythm_Homo sapiens_hsa04710 | 0.99495677 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97951282 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.97447545 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94696692 |
| 24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.93474927 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92327495 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 0.90383793 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89768600 |
| 28 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88220056 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.83931941 |
| 30 | Circadian entrainment_Homo sapiens_hsa04713 | 0.82945630 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82682002 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80491564 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 0.79169172 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79094331 |
| 35 | Nicotine addiction_Homo sapiens_hsa05033 | 0.76436157 |
| 36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76270432 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 0.73237320 |
| 38 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72553639 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 0.70340838 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67759137 |
| 41 | Insulin secretion_Homo sapiens_hsa04911 | 0.64097041 |
| 42 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63939722 |
| 43 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63046758 |
| 44 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62859021 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61137002 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57692130 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56444458 |
| 48 | Bladder cancer_Homo sapiens_hsa05219 | 0.56206616 |
| 49 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55196623 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53387541 |
| 51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53185752 |
| 52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51546352 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51523560 |
| 54 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51352369 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51096921 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.50965846 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50868408 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48763017 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48660789 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47635891 |
| 61 | Purine metabolism_Homo sapiens_hsa00230 | 0.47280858 |
| 62 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46805460 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46778444 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46774657 |
| 65 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.45332068 |
| 66 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42561190 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41151879 |
| 68 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.41045660 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39606477 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39562775 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.39394358 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38987542 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38904600 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38814262 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38632334 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.37283892 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.36961803 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36727834 |
| 79 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.36028852 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.35587855 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35117648 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34671156 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34490225 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33922812 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32694627 |
| 86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32430246 |
| 87 | Cocaine addiction_Homo sapiens_hsa05030 | 0.32285973 |
| 88 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31702516 |
| 89 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31491405 |
| 90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.31277336 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31219205 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.30510651 |
| 93 | Long-term potentiation_Homo sapiens_hsa04720 | 0.28498471 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28310916 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27741675 |
| 96 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27658567 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27327763 |
| 98 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26623783 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25968576 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.25955595 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25489473 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25247881 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24159917 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.23971846 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23937107 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23883097 |
| 107 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.23034110 |
| 108 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.21726549 |
| 109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21073593 |
| 110 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.20153461 |
| 111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.19942694 |
| 112 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.19785033 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19549216 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17897342 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.17584554 |
| 116 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17565679 |
| 117 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.17125931 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17069298 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16481249 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16305544 |
| 121 | Alcoholism_Homo sapiens_hsa05034 | 0.15439096 |
| 122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15057430 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.14281319 |
| 124 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.13457852 |
| 125 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.13404838 |
| 126 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.13403741 |
| 127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13158690 |
| 128 | Mineral absorption_Homo sapiens_hsa04978 | 0.12373176 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.12044086 |
| 130 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.11720551 |
| 131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.11633185 |
| 132 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.10369693 |
| 133 | RNA degradation_Homo sapiens_hsa03018 | 0.09789573 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.09575539 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.08903567 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.08738132 |
| 137 | Taste transduction_Homo sapiens_hsa04742 | 0.07670012 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.07654444 |
| 139 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.07508799 |
| 140 | Tight junction_Homo sapiens_hsa04530 | 0.07310574 |
| 141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.06976978 |
| 142 | Glioma_Homo sapiens_hsa05214 | 0.06893395 |
| 143 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.06101402 |
| 144 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.05971787 |
| 145 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.05696570 |
| 146 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.05085906 |
| 147 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.04914268 |
| 148 | Long-term depression_Homo sapiens_hsa04730 | 0.04786133 |
| 149 | Galactose metabolism_Homo sapiens_hsa00052 | 0.04571712 |
| 150 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.04161752 |
| 151 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.03844097 |
| 152 | Bile secretion_Homo sapiens_hsa04976 | 0.03473049 |
| 153 | Melanogenesis_Homo sapiens_hsa04916 | 0.03252035 |
| 154 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.02945967 |
| 155 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02775236 |

